Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



ROCHE ROBERT P JR Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 30,220 shares @ $2.73, valued at $82.5k
Granted 58,246 options to buy @ $2.73, valued at $159k
07/18/2019 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns: Disposed/sold 18,000 shares @ $0
Disposed/sold 20,000 options to buy @ $15.8, valued at $316k
Disposed/sold 10,000 options to buy @ $14.27, valued at $142.7k
Disposed/sold 7,500 options to buy @ $6.12, valued at $45.9k
Disposed/sold 7,500 options to buy @ $6.84, valued at $51.3k
Disposed/sold 7,500 options to buy @ $4.36, valued at $32.7k
Disposed/sold 7,500 options to buy @ $4.8, valued at $36k
06/14/2019 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 23,973 shares @ $2.92, valued at $70k
Granted 46,729 options to buy @ $2.92, valued at $136.4k
06/07/2019 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns: Granted 4,500 shares @ $0
Granted 7,500 options to buy @ $4.8, valued at $36k
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2018 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns: Granted 4,500 shares @ $0
Granted 7,500 options to buy @ $4.36, valued at $32.7k
06/11/2018 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 76,548 options to buy @ $2.7, valued at $206.7k
05/15/2018 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on Egalet Corp
Txns: Granted 75,000 options to buy @ $0.6, valued at $45k
06/23/2017 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns: Granted 4,500 shares @ $0
Granted 7,500 options to buy @ $6.84, valued at $51.3k
06/12/2017 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on Egalet Corp
Txns: Granted 58,133 options to buy @ $2.38, valued at $138.4k
06/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2017 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on Egalet Corp
06/28/2016 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.
Txns: Granted 4,500 shares @ $0
Granted 7,500 options to buy @ $6.12, valued at $45.9k
06/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/02/2013 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
08/12/2013 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 18,172 shares @ $0
Granted 20,000 options to buy @ $4.54, valued at $90.8k
06/07/2013 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
04/29/2013 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
01/03/2013 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
10/01/2012 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
07/03/2012 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
06/11/2012 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
04/03/2012 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
01/04/2012 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
10/04/2011 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
09/19/2011 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
07/05/2011 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
03/07/2011 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.
12/23/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
12/16/2009 4 ROCHE ROBERT P JR (Exec. VP, WW Pharm Ops) has filed a Form 4 on CEPHALON INC
Txns: Paid exercise price by delivering 1,503 shares @ $59.13, valued at $88.9k
12/15/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy